Search Results - "HYSLOP, Deborah K"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2

    Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor by Wong, Erik H.F., Sonders, Mark S., Amara, Susan G., Tinholt, Paula M., Piercey, Montford F.P., Hoffmann, William P., Hyslop, Deborah K., Franklin, Stanley, Porsolt, Roger D., Bonsignori, Alberto, Carfagna, Nicola, McArthur, Robert A.

    Published in Biological psychiatry (1969) (01-05-2000)
    “…Background: Reboxetine is a potent antidepressant, with efficacy comparable to that of imipramine, desipramine, and fluoxetine, and has improved side-effect…”
    Get full text
    Journal Article
  3. 3

    Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist : comparison to other dopamine receptor agonists by PIERCEY, M. F, HOFFMANN, W. E, SMITH, M. W, HYSLOP, D. K

    Published in European journal of pharmacology (19-09-1996)
    “…Pramipexole, an amino-benzathiazole [(S)-4,5,6,7-tetrahydro-N-6-propyl-2, 6-benzothiazolediamine dihydrochloride monohydrate] direct-acting dopamine receptor…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors by Piercey, M F, Hyslop, D K, Hoffmann, W E

    Published in Brain research (11-07-1997)
    “…Previous studies have demonstrated that both direct- and indirect-acting dopamine (DA) receptor agonists excite type II neurons in the anterior caudate (CN) by…”
    Get full text
    Journal Article
  7. 7

    Inhibition of dopamine neuron firing by pramipexole, a dopamine D 3 receptor-preferring agonist: comparison to other dopamine receptor agonists by Piercey, Montford F., Hoffmann, William E., Smith, Martin W., Hyslop, Deborah K.

    Published in European journal of pharmacology (19-09-1996)
    “…Pramipexole, an amino-benzathiazole [( S)-4,5,6,7-tetrahydro- N-6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate] direct-acting dopamine receptor…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Excitation of type II anterior caudate neurons by stimulation of dopamine D 3 receptors by Piercey, Montford F, Hyslop, Deborah K, Hoffmann, William E

    Published in Brain research (11-07-1997)
    “…Previous studies have demonstrated that both direct- and indirect-acting dopamine (DA) receptor agonists excite type II neurons in the anterior caudate (CN) by…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Excitation of type II caudate neurons by systemic administration of dopamine agonists by Piercey, Montford F., Hyslop, Deborah K., Hoffmann, William E.

    Published in Brain research (15-01-1996)
    “…Using chloral hydrate anesthetized rats, dopamine (DA) agonists were evaluated for their systemic effects on firing rates of DA neurons in rat substantia nigra…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment by Yocca, F D, Eison, A S, Hyslop, D K, Ryan, E, Taylor, D P, Gianutsos, G

    Published in Life sciences (1973) (1991)
    “…The effect of continuous treatment with the selective 5-HT1A agonist gepirone upon 5-HT2-mediated behavior and cortical 5-HT2 receptor binding sites was…”
    Get more information
    Journal Article
  15. 15

    Effect of irreversible loss of muscarinic receptors on (3H)-acetylcholine release from the hippocampus by Sethy, V H, Hyslop, D K

    Published in Neuropharmacology (01-02-1990)
    “…The role of muscarinic receptors in the regulation of (3H)-acetylcholine (3H-Ach) release from the hippocampus was investigated with the irreversible…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Radioreceptor assay of dopamine binding activity in human serum after tiospirone administration by Hyslop, D K, Westrick, M L, Shukla, U A, Taylor, D P

    Published in Therapeutic drug monitoring (1989)
    “…Tiospirone has demonstrated preclinical activities that predict utility as an antipsychotic drug which lacks the potential to produce extrapyramidal side…”
    Get more information
    Journal Article
  18. 18

    THE INTERACTION OF TRAZODONE WITH RAT BRAIN MUSCARINIC CHOLINOCEPTORS by HYSLOP, DEBORAH K., TAYLOR, DUNCAN P.

    Published in British journal of pharmacology (01-01-1980)
    “…The muscarinic receptor binding of trazodone, a new nontricyclic antidepressant, was compared with established tricyclic antidepressants. The ability to…”
    Get full text
    Journal Article
  19. 19
  20. 20